What is WESTAR HYPERNOVA?
WESTAR HYPERNOVA is Cyanagen’s most powerful chemiluminescent (ECL) substrate, built on exclusive patented technology to achieve attogram-level protein detection — outperforming the market’s current top-tier substrates.
Direct substitutes include: Benchmarked against WESTAR SUPERNOVA (Cyanagen), SuperSignal™ West Femto (Thermo Scientific™), Amersham™ ECL Select™ (GE Healthcare), and Clarity Max™ (Bio-Rad).
Key Performance Data at a Glance

Why Choose WESTAR HYPERNOVA
Superior Performance vs. Top-Tier Substrates
WESTAR HYPERNOVA exhibits superior performance compared to the top performers currently on the market, including WESTAR SUPERNOVA, SuperSignal West Femto, Amersham ECL Select, and Clarity Max.
Extreme Sensitivity and Wide Linear Range
With an R² value greater than 0.99, WESTAR HYPERNOVA offers a wide linear dynamic range and produces up to a 10-fold higher signal-to-noise ratio than all current top-level ECL substrates, enabling accurate interpretation of even the faintest bands.
Save Precious Samples and Antibodies
Because WESTAR HYPERNOVA generates much higher signal intensity, considerably smaller protein samples can be loaded to achieve the same results — 8 times less protein than Amersham ECL Select for equal signal, and 10 times less primary antibody than Clarity Max for similar performance.
Shorten Exposure Time
WESTAR HYPERNOVA delivers the same signal intensity and sensitivity as Clarity Max in just 10 seconds of exposure instead of 5 minutes, saving time and increasing productivity.
High Reproducibility
In a simplified multiwell assay, WESTAR HYPERNOVA’s performance is not affected by common sources of variability such as sample loading, transfer efficiency, blocking, or antibody performance — with triplicate variability below 20%.